Editor’s Note: Notice the classic Hegelian dialectic present in this argument: A deadly avian flu virus was synthesized in a lab, and gov’ts warned of a flu virus recipe ‘falling into terrorist hands’ – so gov’ts call for keeping this research ‘top secret’. Now we’re told that it’s too late, the info is already out there. We are witnessing the beginning of a new psy-op. According this dialectic, we are all inevitable victims of bio-terrorism via a rogue state, or lone gunman. Nowhere in this mainstream argument do ‘experts’ raise the question of why so many lethal flu viruses are being cooked-up in labs all around the world, when there is still no data present to show that flu vaccines are of any real benefit to the public. In fact, there are more documented arguments to show that when big pharma distribute their products into the public sphere, increased flu incidences can, and will occur. For the skeptic, a simple question: Why do we need to develop so many deadly flu strains in labs to begin with? Answer: the create supposed antidotes for specific viruses that do not exist in the real world, but do exist in labs. Loyal users of flu shots should note here – the catastrophic risks obviously outweigh the nonexistent rewards.
Steve Connor
The Independent
December 22, 2011
Attempts to censor details of controversial influenza experiments that created a highly infectious form of bird-flu virus are unlikely to stop the information from leaking out, according to scientists familiar with the research.
The US Government has asked the editors of two scientific journals to refrain from publishing key parts of research on the H5N1 strain of bird-flu in order to prevent the information falling into the hands of terrorists intent on recreating the same flu strain for use as a bioweapon.
However, scientists yesterday condemned the move. Some said that the decision comes too late because the information has already been shared widely among flu researchers, while others argued that the move could obstruct attempts to find new vaccines and drugs against an infectious form of human H5N1 if it appeared naturally.
Professor Richard Ebright, a molecular biologist at Rutgers University in Piscataway, New Jersey, said that the research, which was funded by the US Government, should never have been done without first assessing the risks and benefits.
